Pyelonephritis (Kidney Infection)

Pyelonephritis is a bacterial infection of the kidney — the most serious of the common urinary tract infections (UTIs). Most UTIs are confined to the bladder, where they cause the familiar burning and urgency of cystitis. Pyelonephritis is what happens when those bacteria climb higher, past the bladder and up the ureters, until they reach the kidney itself. Because the kidney is a richly blood-supplied organ wired directly into the circulation, an infection here can spill bacteria into the bloodstream and set off sepsis. That is the whole reason a kidney infection is treated so much more urgently than a bladder infection: the classic combination of fever, flank pain, and nausea is the body's warning that a routine UTI has become a systemic illness. The good news is that when it is caught early and treated with the right antibiotics, most people recover completely — and much of the danger comes from delay.

Table of Contents

  1. What Is Pyelonephritis?
  2. How It Differs From a Bladder Infection
  3. Symptoms & Warning Signs
  4. Causes & How Infection Ascends
  5. Risk Factors
  6. Diagnosis
  7. Treatment
  8. Complications
  9. Acute vs Chronic Pyelonephritis
  10. Prevention
  11. When to Seek Emergency Care
  12. Key Research Papers
  13. Connections

What Is Pyelonephritis?

The name breaks down into its Greek roots: pyelo- (the renal pelvis, the funnel-shaped chamber where each kidney collects urine), nephro- (kidney), and -itis (inflammation). Put together, pyelonephritis means inflammation of the kidney and its collecting system caused by infection. In practice it refers to a bacterial infection that has taken hold in the substance of one or both kidneys rather than staying in the bladder below.

Doctors group urinary tract infections by where they sit. A lower UTI involves the bladder (cystitis) or urethra (urethritis) and is usually uncomfortable but low-risk. An upper UTI — pyelonephritis — involves the kidney and is a systemic infection that can become dangerous. The single feature that most often marks the difference is fever: a bladder infection typically does not cause one, while a kidney infection usually does.

By far the most common culprit is Escherichia coli (E. coli), the gut bacterium responsible for roughly 70–90% of uncomplicated cases. Kidney infection is also much more common in women than in men. In one large population-based analysis of otherwise-healthy adults, acute pyelonephritis occurred in roughly 12–13 women per 10,000 per year as outpatients and about 3–4 per 10,000 requiring hospitalization, with rates several-fold lower in men. Infections are described as uncomplicated when they occur in an otherwise-healthy, non-pregnant adult with a normal urinary tract, and complicated when there is an underlying problem — obstruction, a stone, a catheter, pregnancy, diabetes, a transplanted or single kidney, or a weakened immune system — that raises the risk of failure and complications.

How It Differs From a Bladder Infection

Because pyelonephritis and cystitis are two ends of the same disease process, they can be confusing to tell apart. The distinction matters enormously, though, because it changes how urgently and how aggressively the infection is treated. The table below summarizes the practical differences.

Feature Cystitis (bladder infection) Pyelonephritis (kidney infection)
Location Lower tract — the bladder Upper tract — the kidney
Fever Usually none Common, often high (≥ 38 °C / 100.4 °F) with shaking chills
Pain Burning on urination; pressure low in the pelvis Flank or back pain, over the ribs at the side (costovertebral angle)
Whole-body illness Feel basically well Nausea, vomiting, exhaustion — genuinely sick
Risk level Low; rarely serious Can lead to bloodstream infection and sepsis
Typical treatment Short oral antibiotic course, often started empirically Longer course, urine culture guided, sometimes IV / hospital

A useful rule of thumb: if a urinary infection comes with a fever, back pain, or vomiting, treat it as a possible kidney infection until proven otherwise. Someone can have both sets of symptoms at once — the burning of cystitis and the fever and flank pain of pyelonephritis — because the kidney infection usually started as a bladder infection that climbed.

Symptoms & Warning Signs

Acute pyelonephritis often develops quickly, over a matter of hours to a day or two. Typical symptoms include:

Older adults can present atypically. Instead of the classic fever-and-flank-pain picture, an elderly person with pyelonephritis may show up with new confusion, weakness, loss of appetite, or a fall — sometimes without much fever at all. A low threshold for testing the urine and checking for infection is wise in this group.

The symptoms that turn a kidney infection into an emergency — signs of sepsis and the inability to keep fluids down — are covered in When to Seek Emergency Care below.

Causes & How Infection Ascends

The vast majority of kidney infections follow an ascending route. It usually unfolds in stages:

  1. Bacteria from the bowel — most often E. coli — colonize the skin and tissues around the urethral opening.
  2. They travel up the short urethra into the bladder, causing cystitis.
  3. From the bladder, they climb the ureters — the thin tubes that carry urine down from each kidney — and finally reach the renal pelvis and kidney tissue.

Several things make that climb easier. The bacteria that cause most kidney infections are uropathogenic strains equipped with hair-like appendages (P-fimbriae and other adhesins) that let them grip the lining of the urinary tract and resist being flushed out by the urine stream. Anything that lets urine pool or flow backward — a blockage, a stone, or urine refluxing from the bladder back up the ureters (vesicoureteral reflux) — hands these bacteria a ladder.

Women are far more susceptible for a simple anatomical reason: the female urethra is short and its opening sits close to the anus and vagina, so gut bacteria have a much shorter trip to the bladder. This is why the same infection that is common and usually mild in young women is comparatively rare in men and, when it does occur in a man, is more often treated as complicated.

Although E. coli dominates, other organisms cause a minority of cases: Klebsiella, Proteus (linked with stone formation and alkaline urine), Enterococcus, and — especially in catheterized or hospitalized patients — Pseudomonas and other resistant bacteria. Young, sexually active women occasionally grow Staphylococcus saprophyticus. Much less commonly, a kidney infection can arrive by the bloodstream rather than by climbing — for example, when Staphylococcus aureus in the blood seeds the kidney — but this hematogenous route is the exception, not the rule.

Risk Factors

Anything that increases bacterial exposure, slows urine flow, or weakens defenses raises the risk of pyelonephritis:

Diagnosis

Diagnosis rests on the clinical picture — fever plus flank pain plus urinary symptoms — confirmed by testing the urine.

Imaging is not routine. A healthy adult who fits the classic picture and starts improving on antibiotics usually needs no scan. Imaging is reserved for situations where something more may be going on:

When imaging is needed, contrast-enhanced CT is the most sensitive test for abscesses, obstruction, and gas-forming (emphysematous) infection. Ultrasound is radiation-free and is preferred in pregnancy and as a quick screen for a blocked, swollen kidney (hydronephrosis).

Treatment

Pyelonephritis is treated with antibiotics, and the central decision is whether a person can be managed at home with pills or needs to be in the hospital on an IV. That choice hinges on how sick they are, whether they can keep fluids and medicine down, and whether the infection is complicated.

Outpatient oral treatment

Someone who is not severely ill, is hemodynamically stable, can tolerate fluids and oral medication, is not pregnant, and has a reliable way to follow up can usually be treated at home. Where local resistance allows, first-line options include a fluoroquinolone — ciprofloxacin 500 mg twice daily for 7 days or levofloxacin 750 mg once daily for 5 days. Randomized trials support these shorter courses: a 7-day course of ciprofloxacin was found non-inferior to 14 days, and a 5-day, high-dose levofloxacin course performed comparably to longer regimens. If local E. coli resistance to fluoroquinolones exceeds about 10%, guidelines advise giving one long-acting initial parenteral dose (such as ceftriaxone or a consolidated aminoglycoside dose) before switching to oral therapy. Trimethoprim-sulfamethoxazole for 14 days is an option only when the cultured organism is known to be susceptible. Oral beta-lactams are generally less effective for kidney infection and are used as backups.

Hospital IV treatment

Admission for intravenous antibiotics is warranted for severe illness or sepsis, persistent vomiting, pregnancy, hemodynamic instability, a complicated urinary tract, uncertain ability to take medication reliably, or failure of outpatient therapy. Empiric IV choices include ceftriaxone, an intravenous fluoroquinolone, piperacillin-tazobactam, or — when extended-spectrum beta-lactamase (ESBL) organisms are likely — a carbapenem, sometimes with an aminoglycoside. Once a patient has been afebrile and clearly improving for about a day or two, treatment is switched to a targeted oral antibiotic guided by the culture, with a total course commonly running 7 to 14 days depending on the drug and severity.

Antibiotic resistance and source control

Resistance is a growing problem and shapes every treatment decision. Resistance of E. coli to trimethoprim-sulfamethoxazole and to fluoroquinolones has risen steadily, and fluoroquinolones now carry warnings about tendon rupture, aortic injury, and nervous-system and blood-sugar effects, so they are used more judiciously than in the past. ESBL-producing and even carbapenem-resistant organisms are increasingly encountered, which is why culture-guided therapy matters and why newer agents (for example, plazomicin) are held in reserve for multidrug-resistant infections. Finally, antibiotics cannot succeed alone when there is pus or a blockage: an abscess must be drained and an obstructing stone relieved. This source control is as important as the drug itself.

Complications

Most people treated promptly recover fully. The complications below are what make early treatment matter:

Acute vs Chronic Pyelonephritis

Acute pyelonephritis is the sudden infection described throughout this article — it comes on fast, is treated with antibiotics, and in most healthy people resolves without lasting harm.

Chronic pyelonephritis is a different animal. It is a pattern of repeated or persistent kidney infection accompanied by progressive scarring, and it almost never occurs without an underlying structural problem driving it — most often vesicoureteral reflux (so-called reflux nephropathy, frequently rooted in childhood), long-standing obstruction, or stones. Over years, chronic pyelonephritis can leave the kidneys shrunken and scarred, cause hypertension, and erode kidney function toward chronic kidney disease. The key point is that treating chronic pyelonephritis means fixing the root cause — correcting reflux, relieving obstruction, removing stones — not simply repeating courses of antibiotics.

A rare and destructive chronic variant, xanthogranulomatous pyelonephritis, typically develops around a large staghorn stone with chronic obstruction (often from Proteus). It gradually replaces normal kidney tissue with lipid-laden inflammatory cells and usually requires surgical removal of the affected kidney.

Prevention

Preventing pyelonephritis largely means preventing bladder infections and treating them before they climb:

When to Seek Emergency Care

A bladder infection can usually wait for a routine clinic visit. A kidney infection — fever plus flank pain plus feeling genuinely ill — deserves same-day medical attention, and certain features make it an emergency. Seek urgent or emergency care if you have:

The bottom line: burning and urgency alone can be handled routinely, but fever, back pain, vomiting, or feeling dangerously unwell mean the infection may have reached the kidney or the blood — and that is when hours matter.

↑ Back to Table of Contents


Key Research Papers

  1. Johnson JR, Russo TA. Acute Pyelonephritis in Adults. New England Journal of Medicine. 2018;378(1):48-59.
  2. Gupta K, Hooton TM, Naber KG, et al. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clinical Infectious Diseases. 2011;52(5):e103-e120.
  3. Hooton TM. Uncomplicated Urinary Tract Infection. New England Journal of Medicine. 2012;366(11):1028-1037.
  4. Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-Based Epidemiologic Analysis of Acute Pyelonephritis. Clinical Infectious Diseases. 2007;45(3):273-280.
  5. Foxman B. Urinary Tract Infection Syndromes: Occurrence, Recurrence, Bacteriology, Risk Factors, and Disease Burden. Infectious Disease Clinics of North America. 2014;28(1):1-13.
  6. Foxman B. The epidemiology of urinary tract infection. Nature Reviews Urology. 2010;7(12):653-660.
  7. Talan DA, Stamm WE, Hooton TM, et al. Comparison of Ciprofloxacin (7 Days) and Trimethoprim-Sulfamethoxazole (14 Days) for Acute Uncomplicated Pyelonephritis in Women: A Randomized Trial. JAMA. 2000;283(12):1583-1590.
  8. Sandberg T, Skoog G, Hermansson AB, et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. The Lancet. 2012;380(9840):484-490.
  9. Peterson J, Kaul S, Khashab M, et al. A Double-Blind, Randomized Comparison of Levofloxacin 750 mg Once-Daily for Five Days With Ciprofloxacin 400/500 mg Twice-Daily for 10 Days for the Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis. Urology. 2008;71(1):17-22.
  10. Huang JJ, Tseng CC. Emphysematous Pyelonephritis: Clinicoradiological Classification, Management, Prognosis, and Pathogenesis. Archives of Internal Medicine. 2000;160(6):797-805.
  11. Hill JB, Sheffield JS, McIntire DD, Wendel GD. Acute Pyelonephritis in Pregnancy. Obstetrics & Gynecology. 2005;105(1):18-23.
  12. Wagenlehner FME, Cloutier DJ, Komirenko AS, et al. Once-Daily Plazomicin for Complicated Urinary Tract Infections. New England Journal of Medicine. 2019;380(8):729-740.

Live PubMed Searches

These links open live PubMed searches for the listed keywords — results update as new studies are indexed.

  1. Acute pyelonephritis treatment — PubMed search
  2. Pyelonephritis antibiotic resistance — PubMed search
  3. Acute pyelonephritis in pregnancy — PubMed search
  4. Emphysematous pyelonephritis — PubMed search
  5. Chronic pyelonephritis & reflux nephropathy — PubMed search
  6. Pyelonephritis imaging (CT) — PubMed search
  7. Short-course antibiotics for pyelonephritis — PubMed search

↑ Back to Table of Contents

Connections

↑ Back to Table of Contents